PAHO 21 countries Current AMR Coordinated n/a n/a n/a 16 pathogens n/a n/a (519 (since surveillance by WHO (all sample 188) laboratories) 1996) and types) antimicrobial EMRO n/a AMR Funded by n/a n/a n/a 28 species n/a n/a (EMRO surveillance ECDC (all sample Regional proposed Program for (formerly 7 surveillance pathogens, of blood and CSF) formerly ARMed29, 2005) WPRO 13 countries Current AMR Coordinated n/a n/a n/a 26 bacteria of n/a Drug (WPRO (14 surveillance by WHO health resistance ‘public Regional importance’ data Program for reported annually to of regional 189) office (4–15 antibiotics); annual reports
PAHO 188) 21 countries (519 laboratories) Current (since 1996) AMR surveillance and antimicrobial Coordinated by WHO n/a n/a n/a 16 pathogens (all sample types) n/a n/a EMRO (EMRO Regional Program for surveillance of formerly ARMed29, n/a AMR surveillance Funded by ECDC n/a n/a n/a 28 species (all sample proposed (formerly 7 pathogens, blood and CSF) n/a n/a WPRO (WPRO Regional Program for of 189) 13 countries (14 Current AMR surveillance Coordinated by WHO n/a n/a n/a 26 bacteria of ‘public health importance’ n/a Drug resistance data reported annually to regional office (4–15 antibiotics); annual reports 2005)
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx